Labo Euromedis (FRA:61R) GF Score: 61/100 (As of Jul. 14, 2026) — 13% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:61R Labo Euromedis FRA:61R
61 GF Score
Price €4.76
GF Value €4.35
! 6 Warning Signs
View Full Analysis

What is Labo Euromedis GF Score?

Labo Euromedis FRA:61R 61 GF Score is 61 as of Jul. 14, 2026, which is 13% above its 10-year median of 54.00. GuruFocus rates FRA:61R with a GF Score™ of 61/100 and a GF Value™ of €4.35. The stock has 6 warning signs investors should review.

Labo Euromedis has the GF Score of 61, which implies that the company might have Poor future performance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 7/10
2. Profitability Rank : 4/10
3. Growth Rank : 1/10
4. GF Value Rank : 6/10
5. Momentum Rank : 6/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Labo Euromedis might have Poor future performance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Labo Euromedis  (FRA:61R) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Labo Euromedis GF Score Related Terms

FRA:61R vs MCK, CAH, COR: GF Score Comparison

For the Medical Distribution subindustry, Labo Euromedis's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labo Euromedis GF Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Labo Euromedis's GF Score distribution charts can be found below:

* The bar in red indicates where Labo Euromedis's GF Score falls into.


FRA:61R
61GF Score
Labo Euromedis FRA:61R
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 61 mean?
Labo Euromedis (FRA:61R) has a GF Score of 61 as of Jul. 14, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Labo Euromedis and its competitors. This is 13% above median its historical median of 54.00. Over the past decade, Labo Euromedis' GF Score has ranged from 22.00 to 74.00.
Is Labo Euromedis' GF Score too high?
Labo Euromedis' current GF Score of 61 is 13% above median its 10-year median of 54.00. Over the past 10 years, this metric has ranged from a low of 22.00 to a high of 74.00. Overall, Labo Euromedis has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Labo Euromedis' GF Score compare to MCK and CAH?
Labo Euromedis' GF Score of 61 can be compared against companies in the Medical Distribution industry. Historically, Labo Euromedis' own GF Score has ranged from 22.00 to 74.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Distribution company?
A good GF Score depends on the Medical Distribution industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Labo Euromedis and its competitors. Labo Euromedis's current GF Score is 61, which is 13% above median its own 10-year median of 54.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labo Euromedis stock overvalued right now?
Labo Euromedis (FRA:61R) has a current GF Score of 61. The stock's GF Value™ is €4.35, compared to a current price of €4.76 — trading 9.4% above its estimated fair value. The current GF Score is 61, which is 13% above median its 10-year median of 54.00. Labo Euromedis' overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Labo Euromedis (FRA:61R), the current GF Score is 61 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Labo Euromedis (FRA:61R) Overvalued in 2026?

Based on GuruFocus' analysis, Labo Euromedis stock appears to be overvalued. The current stock price of €4.76 is trading 9.4% above its estimated GF Value™ of €4.35.

Key valuation signals for FRA:61R:

  • GF Score: 61 (13% above median its 10-year median of 54.00)
  • GF Value™: €4.35 vs. price of €4.76 (9.4% above fair value)
  • GF Score™: 61/100 with 6 warning signs

No single metric tells the full story. See the FRA:61R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Labo Euromedis Business Description

Address ZI de la Tuilerie, Neuilly-sous-Clermont, FRA, 60290
Labo Euromedis is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.
61GF Score

Get the complete analysis for FRA:61R

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.76
Price
€4.35
GF Value